John Mendlein - Insider Trading & Ownership

Summary
The estimated net worth of John Mendlein is at least $109K dollars as of May 30, 2025. John Mendlein is the Director of FATE THERAPEUTICS INC and owns shares of FATE THERAPEUTICS INC (FATE) stock worth about $109K.
Signature
/s/ Cindy Tahl, as Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of John Mendlein

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
FATE FATE THERAPEUTICS INC Director $109K May 29, 2025
OMGAQ Omega Therapeutics, Inc. Director Jun 20, 2024

Insider Transactions Reported by John Mendlein:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.